Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Prestige Consumer Healthcare (PBH) EBITDA Margin (2016 - 2025)

Prestige Consumer Healthcare has reported EBITDA Margin over the past 16 years, most recently at 16.96% for Q4 2025.

  • Quarterly results put EBITDA Margin at 16.96% for Q4 2025, up 63.0% from a year ago — trailing twelve months through Dec 2025 was 17.8% (down 29.0% YoY), and the annual figure for FY2025 was 18.58%, up 24.0%.
  • EBITDA Margin for Q4 2025 was 16.96% at Prestige Consumer Healthcare, up from 15.64% in the prior quarter.
  • Over the last five years, EBITDA Margin for PBH hit a ceiling of 21.4% in Q4 2023 and a floor of 84.87% in Q1 2023.
  • Median EBITDA Margin over the past 5 years was 17.57% (2025), compared with a mean of 12.97%.
  • Biggest five-year swings in EBITDA Margin: tumbled -10595bps in 2023 and later surged 10058bps in 2024.
  • Prestige Consumer Healthcare's EBITDA Margin stood at 18.74% in 2021, then increased by 14bps to 21.39% in 2022, then increased by 0bps to 21.4% in 2023, then fell by -24bps to 16.33% in 2024, then rose by 4bps to 16.96% in 2025.
  • The last three reported values for EBITDA Margin were 16.96% (Q4 2025), 15.64% (Q3 2025), and 21.19% (Q2 2025) per Business Quant data.